1-4 of 4
Chikara Murakata
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

K858, a Novel Inhibitor of Mitotic Kinesin Eg5 and Antitumor Agent, Induces Cell Death in Cancer Cells

Ryuichiro Nakai, Shin-ichi Iida, Takeshi Takahashi, Tetsuya Tsujita, Seiho Okamoto, Chie Takada, Kazuhito Akasaka, Shunji Ichikawa, Hiroyuki Ishida, Hideaki Kusaka, Shiro Akinaga, Chikara Murakata, Shinobu Honda, Masayuki Nitta, Hideyuki Saya, Yoshinori Yamashita
Journal: Cancer Research
Cancer Res (2009) 69 (9): 3901–3909.
https://doi.org/10.1158/0008-5472.CAN-08-4373
Published: 30 April 2009
View article titled, K858, a Novel Inhibitor of Mitotic Kinesin Eg5 and Antitumor Agent, Induces Cell Death in Cancer Cells
Open the PDF for K858, a Novel Inhibitor of Mitotic Kinesin Eg5 and Antitumor Agent, Induces Cell Death in Cancer Cells in another window
Includes: Multimedia, Supplementary data
Journal Articles

Discovery and characterization of new antitumor agents targeting mitotic kinesin Eg5

Ryuichiro Nakai, Takeshi Takahashi, Tetsuya Tsujita, Seiho Okamoto, Chie Takada, Kazuto Akasaka, Hiroyuki Ishida, Shin-Ichi Iida, Shinobu Honda, Masayuki Nitta, Hideyuki Saya, Hideaki Kusaka, Shiro Akinaga, Chikara Murakata, Yoshinori Yamashita
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1391.
Published: 01 May 2005
View article titled, Discovery and characterization of new antitumor agents targeting mitotic kinesin Eg5
Journal Articles

KF25706, a Novel Oxime Derivative of Radicicol, Exhibits in Vivo Antitumor Activity via Selective Depletion of Hsp90 Binding Signaling Molecules

Shiro Soga, Leonard M. Neckers, Theodor W. Schulte, Yukimasa Shiotsu, Kazuhito Akasaka, Hiroaki Narumi, Tsutomu Agatsuma, Yoji Ikuina, Chikara Murakata, Tatsuya Tamaoki, Shiro Akinaga
Journal: Cancer Research
Cancer Res (1999) 59 (12): 2931–2938.
Published: 15 June 1999
View article titled, KF25706, a Novel Oxime Derivative of Radicicol, Exhibits <em>in Vivo</em> Antitumor Activity via Selective Depletion of Hsp90 Binding Signaling Molecules
Open the PDF for KF25706, a Novel Oxime Derivative of Radicicol, Exhibits <em>in Vivo</em> Antitumor Activity via Selective Depletion of Hsp90 Binding Signaling Molecules in another window
Journal Articles

Sustained in Vivo Regression of Dunning H Rat Prostate Cancers Treated with Combinations of Androgen Ablation and Trk Tyrosine Kinase Inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555)

Daniel J. George, Craig A. Dionne, Jitesh Jani, Thelma Angeles, Chikara Murakata, John Lamb, John T. Isaacs
Journal: Cancer Research
Cancer Res (1999) 59 (10): 2395–2401.
Published: 15 May 1999
View article titled, Sustained <em>in Vivo</em> Regression of Dunning H Rat Prostate Cancers Treated with Combinations of Androgen Ablation and Trk Tyrosine Kinase Inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555)
Open the PDF for Sustained <em>in Vivo</em> Regression of Dunning H Rat Prostate Cancers Treated with Combinations of Androgen Ablation and Trk Tyrosine Kinase Inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555) in another window